U.S. market Closed. Opens in 55 minutes

CORT | Corcept Therapeutics Incorporated Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for CORT we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is very good and Health is very strong.

Valuation (59%)

Company Industry
P/E Ratio (TTM) 38.17 -18.09
PEG Ratio (TTM) 3.33 -5.18
P/S Ratio (TTM) 8.70 52.20
P/B Ratio (TTM) 8.44 28.91
P/FCF Ratio (TTM) 38.33 -7.12
Price to 5YR AVG Earnings Ratio 55.62 -7.20
Price to 5YR AVG FCF Ratio 39.04 -13.31

Profitability (85%)

Company Industry
ROA (TTM) 18.02% -16.66%
ROE (TTM) 24.68% 27.93%
Net Profit Margin (TTM) 22.48% -796.50%
ROIC 5YR AVG 99.61% -20.53%

Growth (73%)

4QTR AVG 3YR AVG 5YR AVG
EPS 11.26% 18.10% 11.92%
Revenue 10.25% 13.62% 14.14%
Net Income 11.97% 14.53% 7.68%
Cash Flow 91.82% 13.27% 3.41%

Health (72%)

Company Industry
Current Ratio (TTM) 3.70 5.80
Quick Ratio (TTM) 3.64 5.58
D/E Ratio (TTM) 0.00 0.97
Interest Coverage (TTM) 40.03 -7.65
Piotroski F-Score 6 5
Altman Z-Score 25.50 13.09
LTL to 5YR AVG FCF N/A 0.07
Shares Outstanding Growth 5YR AVG -3.71% 40.92%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙